Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ellen G.J. Hulskotte"'
Autor:
Ellen G.J. Hulskotte, Carel A. van Baalen, Marlinda E. M. Dings, Geert van Amerongen, Anna Maria Geretti, Stephen Norley, Rob A. Gruters, Albert D. M. E. Osterhaus, Patrick H. M. Boers
Publikováno v:
Journal of Infectious Diseases, 180, 1133-1141. Oxford University Press
The evolution of simian immunodeficiency virus (SIV)‐specific cytotoxic T lymphocyte precursors (CTLps) and their relationship with virus replication were studied in SIV-infected macaques. After primary viremia, 3 of 8 macaques lost culturable viru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2dd500bddd39bb13ecf11e792be884
https://hdl.handle.net/1765/3695
https://hdl.handle.net/1765/3695
Autor:
Ellen G.J. Hulskotte, Carel A. van Baalen, Marlinda E. M. Dings, Albert D. M. E. Osterhaus, Geert van Amerongen, Anna Maria Geretti
Publikováno v:
Vaccine, 15(11), 1269-1275. Elsevier
Detailed analyses of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocyte (CTL) responses in vaccinated and infected macaques may help to clarify the role of CTL immunity in protection against lentiviruses. Here, the optimal conditions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9180020f7094276023d20815c3b4e8
https://hdl.handle.net/1765/65451
https://hdl.handle.net/1765/65451
Autor:
G. van Amerongen, S. G. Norley, P. De Vries, M. P. Cranage, Anna Maria Geretti, Erling W. Rud, Kees H.J. Siebelink, Ellen G.J. Hulskotte, Albert D. M. E. Osterhaus
Publikováno v:
ResearcherID
To gain further insight into the ability of subunit vaccines to protect monkeys from experimental infection with simian immunodeficiency virus (SIV), two groups of cynomolgus macaques were immunized with either recombinant SIVmac32H-derived envelope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8e4853e9eef15bb47b807281cbefbb
https://doi.org/10.1128/jvi.69.10.6289-6296.1995
https://doi.org/10.1128/jvi.69.10.6289-6296.1995
Autor:
Marnix L. Bosch, Jolande Boes, Jonathan L. Heeney, Petra de Vries, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Ellen G.J. Hulskotte, Stephen Norley
Publikováno v:
Vaccine. 13:1187-1197
Shortly after infection of two rhesus monkeys (Macaca mulatta) either with a SIVmac32H challenge stock or with the same virus that had been passaged in another rhesus monkey for 11 months, SIV-envelope genes were cloned from their peripheral blood mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a593830617c89a13e77041f8a79c52
https://doi.org/10.1016/0264-410x(95)00053-4
https://doi.org/10.1016/0264-410x(95)00053-4
Autor:
Jiuqiao Zhao, Gé S.F. Ruigt, J. Richard Morphy, Mark Craighead, Maria L. Webb, Susan Elizabeth Napier, Chris Riviello, Jeffrey J. Letourneau, Irina Neagu, Rachel Milne, Ard Peeters, Heather A. Zanetakos, Michael Ohlmeyer, Fiona Thomson, Koc-Kan Ho, Leigh Campbell-Wan, Cliona P MacSweeney, Katharine A. Goan, Douglas S. Auld, Jeremy Presland, Stuart A. Best, Jui-Hsiang Chan, Nasrin Ansari, James R. Baker, Ellen G.J. Hulskotte, Hema Desai
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(6)
Synthesis and structure-activity relationships (SAR) of a novel series of vasopressin V(1b) (V(3)) antagonists are described. 2-(4-Oxo-2-aryl-quinazolin-3(4H)-yl)acetamides have been identified with low nanomolar affinity for the V(1b) receptor and g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a649bc2a59fc110b6f0e0bf28067ca98
https://pubmed.ncbi.nlm.nih.gov/21353540
https://pubmed.ncbi.nlm.nih.gov/21353540
Publikováno v:
Vaccine, 16(9/10), 904-915. Elsevier
The development of a safe and effective vaccine for the prevention of AIDS has thus far proven to be extremely difficult, at least in part due to complexities associated with HIV-1 and its pathogenesis. The recent description of individuals transient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd0859314fe1c06ac8fa097014da1847
https://pubmed.ncbi.nlm.nih.gov/9682336
https://pubmed.ncbi.nlm.nih.gov/9682336
Publikováno v:
The Journal of general virology. 79
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9cf1b3a704a3562bb4f9e1db23c41c9
https://pubmed.ncbi.nlm.nih.gov/9519818
https://pubmed.ncbi.nlm.nih.gov/9519818
Publikováno v:
Vaccine, 15(17/18), 1839-1845. Elsevier
The efficiency of paraformaldehyde (PFA) and binary ethylenimine (BEI) in inactivating recombinant vaccinia virus (rVV), present in baby hamster kidney cells expressing simian immunodeficiency virus envelope glycoproteins (SIV-Env), was measured in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6851eb4c6d9dc2096746ec8c7ec8b352
https://pure.eur.nl/en/publications/5c4b081d-634f-42f5-b1f9-6ee4c4da9102
https://pure.eur.nl/en/publications/5c4b081d-634f-42f5-b1f9-6ee4c4da9102
Autor:
Ellen G.J. Hulskotte, Lennart Åkerblom, Marlinda E. M. Dings, Jolande Boes, Sigrid Eriksson, Bror Morein, Peter ten Haaft, Rob Dubbes, S. Norley, Albert D. M. E. Osterhaus, Jonathan L. Heeney, Petra de Vries, Willem Koornstra
Publikováno v:
Vaccine. 12(15)
The immunogenicity and efficacy of an inactivated whole SIVmac (32H) preparation adjuvanted with muramyl dipeptide (SIV-MDP) and a gp120-enriched SIVmac (32H) ISCOM preparation (SIV-ISCOM), were compared by immunizing four rhesus macaques (Macaca mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a965c4244238c6c606211e62cc315ce9
https://pubmed.ncbi.nlm.nih.gov/7887023
https://pubmed.ncbi.nlm.nih.gov/7887023
Autor:
Rob A. Gruters, Edwin Tijhaar, Gerd Sutter, G. van Amerongen, A.D.M.E. Osterhaus, C.H.J Siebelink, Martin Schutten, V Erfle, Richard E. Randall, Ellen G.J. Hulskotte, C. A. van Baalen, A Fleuchaus
Publikováno v:
Vaccine, 17, 2713-2714. Elsevier
Intro: More than 15 years after the discovery of HIV-1 as the causative agent of AIDS, and numerous attempts to develop a vaccine, it has become clear that the efficacy of the currently considered HIV-1 vaccine candidates will generally be limited. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658da4860a6b2c08bd6a034fd5d97091
https://pure.eur.nl/en/publications/31aabe6b-15a4-4227-a6e0-f9d4b2b60b04
https://pure.eur.nl/en/publications/31aabe6b-15a4-4227-a6e0-f9d4b2b60b04